Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Danjou, P; Paty, I; Fruncillo, R; Worthington, P; Unruh, M; Cevallos, W; Martin, P
   A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening
   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
   
   P. Danjou et al., "A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening", BR J CL PH, 48(3), 1999, pp. 367-374
2. Ball, SE; Scatina, JA; Kao, J; Ferron, GM; Fruncillo, R; Mayer, P; Weinryb, I; Guida, M; Hopkins, PJ; Warner, N; Hall, J
   Population distribution and effects on drug metabolism of a genetic variant in the 5 ' promotor region of CYP3A4
   CLINICAL PHARMACOLOGY & THERAPEUTICS
   
   S.E. Ball et al., "Population distribution and effects on drug metabolism of a genetic variant in the 5 ' promotor region of CYP3A4", CLIN PHARM, 66(3), 1999, pp. 288-294
3. TROY S; FRUNCILLO R; OZAWA T; MAMMEN E; HOLLOWAY S; CHIANG S
   ABSOLUTE AND COMPARATIVE SUBCUTANEOUS BIOAVAILABILITY OF ARDEPARIN SODIUM, A LOW-MOLECULAR-WEIGHT HEPARIN
   Thrombosis and haemostasis
   
   S. Troy et al., "ABSOLUTE AND COMPARATIVE SUBCUTANEOUS BIOAVAILABILITY OF ARDEPARIN SODIUM, A LOW-MOLECULAR-WEIGHT HEPARIN", Thrombosis and haemostasis, 78(2), 1997, pp. 871-875
4. FRUNCILLO R; TROY S; PARKER V; MAYERSOHN M; HICKS D; KRAML M; BATTLE M; CHIANG S
   PHARMACOKINETICS OF THE ALDOSE REDUCTASE INHIBITOR TOLRESTAT - STUDIES IN HEALTHY-YOUNG AND ELDERLY MALE AND FEMALE SUBJECTS AND IN SUBJECTS WITH DIABETES
   Clinical pharmacology and therapeutics
   
   R. Fruncillo et al., "PHARMACOKINETICS OF THE ALDOSE REDUCTASE INHIBITOR TOLRESTAT - STUDIES IN HEALTHY-YOUNG AND ELDERLY MALE AND FEMALE SUBJECTS AND IN SUBJECTS WITH DIABETES", Clinical pharmacology and therapeutics, 59(6), 1996, pp. 603-612
5. TROY S; FRUNCILLO R; OZAWA T; MAMMEN E; HOLLOWAY S; CHIANG S
   THE DOSE PROPORTIONALITY OF THE PHARMACOKINETICS OF ARDEPARIN, A LOW-MOLECULAR-WEIGHT HEPARIN, IN HEALTHY-VOLUNTEERS
   Journal of clinical pharmacology
   
   S. Troy et al., "THE DOSE PROPORTIONALITY OF THE PHARMACOKINETICS OF ARDEPARIN, A LOW-MOLECULAR-WEIGHT HEPARIN, IN HEALTHY-VOLUNTEERS", Journal of clinical pharmacology, 35(12), 1995, pp. 1194-1199